 |
 |
|
|
|  PubMed
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 August 2000 | Volume 133 Issue 3 | Pages 192-196
Background: An association between use of zidovudine and didanosine and a rare but life-threatening syndrome of hepatic steatosis, lactic acidosis, and myopathy has been reported.
Objective: To describe the syndrome of hepatic steatosis, lactic acidosis, and myopathy in four patients taking stavudine.
Design: Case series.
Setting: A community hospital in Washington, D.C., and National Institutes of Health Clinical Center, Bethesda, Maryland.
Patients: Two men and two women with HIV-1 infection who were taking stavudine presented with lactic acidosis and elevated levels of aminotransferases. All patients required intensive care.
Measurements: Levels of lactic acid, alanine aminotransferase, aspartate aminotransferase, amylase, and lipase; computed tomography of the abdomen; liver biopsy (two patients); and muscle biopsy (two patients).
Results: Histologic findings consistent with mitochondrial injury confirmed the diagnosis of hepatic or muscle abnormality.
Conclusion: Because hepatic steatosis may be life-threatening, physicians should consider it as a possible cause of elevated hepatic aminotransferase levels among patients taking stavudine.
Author and Article Information
From Warren Grant Magnuson Clinical Center, National Institute of Allergy and Infectious Diseases Intramural AIDS Program, National Cancer Institute, and National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland; and Kaiser Permanente Mid-Atlantic and West End Medical Center, Washington, D.C.
Requests for Single Reprints: Kirk D. Miller, MD, Critical Care Medicine Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Building 10, Room 8C410, Bethesda, MD 20892.
Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.
Current Author Addresses: Dr. Miller: Critical Care Medicine Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Building 10, Room 8C410, Bethesda, MD 20892.
Dr. Cameron: Division of Infectious Diseases, Kaiser Permanente West End Medical Center, 2100 Pennsylvania Avenue NW, Washington, DC 20037.
Dr. Wood: National Cancer Institute, National Institutes of Health, Building 10, Room 13N240, Bethesda, MD 20892.
Dr. Dalakas: National Institute of Neurological Diseases and Stroke, National Institutes of Health, Building 10, Room 4N248, Bethesda, MD 20892.
Dr. Kovacs: Critical Care Medicine Department, Warren Grant Magnuson Clinical Center, Building 10, Room 7D43, National Institutes of Health, Bethesda, MD 20892.
Author Contributions: Conception and design: K.D. Miller, M. Cameron, J.A. Kovacs.
Analysis and interpretation of the data: K.D. Miller, M.C. Dalakas, J.A. Kovacs.
Drafting of the article: K.D. Miller.
Critical revision of the article for important intellectual content: K.D. Miller, M. Cameron, L.V. Wood, M.C. Dalakas, J.A. Kovacs.
Final approval of the article: M. Cameron, M.C. Dalakas, J.A. Kovacs.
Provision of study materials or patients: K.D. Miller, M. Cameron, L.V. Wood, J.A. Kovacs.
Collection and assembly of data: K.D. Miller, M. Cameron, L.V. Wood, M.C. Dalakas. BRIEF COMMUNICATION
Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. Puoti, P. Nasta, F. Gatti, A. Matti, K. Prestini, L. Biasi, and G. Carosi HIV-Related Liver Disease: ARV Drugs, Coinfection, and Other Risk Factors J Int Assoc Physicians AIDS Care (Chic Ill), January 1, 2009; 8(1): 30 - 42. [Abstract] [PDF]
|
|
|
|
 |
|
 P. J. Fall and H. M. Szerlip Lactic Acidosis: From Sour Milk to Septic Shock J Intensive Care Med, September 1, 2005; 20(5): 255 - 271. [Abstract] [PDF]
|
|
|
|
 |
|
 D. C. Rudorf and S. A. Krikorian Adverse Effects Associated With Antiretroviral Therapy and Potential Management Strategies Journal of Pharmacy Practice, August 1, 2005; 18(4): 258 - 277. [Abstract] [PDF]
|
|
|
|
 |
|
 H.-Y. Lai, J.-H. Chen, P.-P. Tsai, M.-W. Ho, and W.-C. Shen Hepatic Steatosis and Pancreatitis Associated with the Use of Stavudine in a Patient with HIV Infection Am. J. Roentgenol., December 1, 2004; 183(6): 1605 - 1607. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mora, I. Zamproni, S. Beccio, R. Bianchi, V. Giacomet, and A. Vigano Longitudinal Changes of Bone Mineral Density and Metabolism in Antiretroviral-Treated Human Immunodeficiency Virus-Infected Children J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 24 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Arenas-Pinto, A D Grant, S Edwards, and I V D Weller Lactic acidosis in HIV infected patients: a systematic review of published cases Sex Transm Inf, August 1, 2003; 79(4): 340 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Marceau, V. Sapin, C. Jacomet, S. Ughetto, L. Cormerais, C. Regagnon, B. Dastugue, H. Peigue-Lafeuille, J. Beytout, and H. Laurichesse Frequency, Risk Factors, and Outcome of Hyperlactatemia in HIV-positive Persons: Implications for the Management of Treated Patients Clin. Chem., July 1, 2003; 49(7): 1154 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Pakyz, Y. Newberry, and G. C. Townsend Human Immunodeficiency Virus Infection: A Focus on Women Journal of Pharmacy Practice, June 1, 2003; 16(3): 170 - 181. [Abstract] [PDF]
|
|
|
|
 |
|
 M Tolomeo, S Mancuso, M Todaro, G Stassi, M Catalano, S Arista, G Cannizzo, E Barbusca, and V Abbadessa Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy J. Clin. Pathol., February 1, 2003; 56(2): 147 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H K Thaker and M H Snow HIV viral suppression in the era of antiretroviral therapy Postgrad. Med. J., January 1, 2003; 79(927): 36 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Vasseur, H. Kawanishi, N. Shah, and M. L. Anderson Type B lactic acidosis: a rare complication of antiretroviral therapy after cardiac surgery Ann. Thorac. Surg., October 1, 2002; 74(4): 1251 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 HIV in Women: An Update AIDS Clinical Care, October 1, 2002; 2002(1001): 1 - 1. [Full Text]
|
|
|
|
 |
|
 H. Masur Acquired Immunodeficiency Syndrome in the Intensive Care Unit: Will Human Immunodeficiency Virus-related Admissions Continue to Decline? Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 258 - 259. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Zell and S. Nielsen Clinical Correlates to Muscle Biopsy Findings in HIV Patients Experiencing Fatigue: A case series J Int Assoc Physicians AIDS Care (Chic Ill), July 1, 2002; 1(3): 90 - 94. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Birkus, M. J. M. Hitchcock, and T. Cihlar Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors Antimicrob. Agents Chemother., March 1, 2002; 46(3): 716 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
NRTI-Associated Mitochondrial Toxicity AIDS Clinical Care, May 1, 2001; 2001(501): 7 - 7. [Full Text]
|
|
|
|
|
|
T. J. Kanmaz and N. J. Lee Significant Toxicities Associated with Antiretroviral Therapy Journal of Pharmacy Practice, December 1, 2000; 13(6): 457 - 474. [Abstract] [PDF]
|
|
|
|
|
|
Hepatic Steatosis and Lactic Acidosis with d4T-Containing Regimens AIDS Clinical Care, October 1, 2000; 2000(1001): 5 - 5. [Full Text]
|
|
|
|
 |
|
 Lactic Acidosis Associated with Stavudine Journal Watch (General), August 11, 2000; 2000(811): 3 - 3. [Full Text]
|
|
